Ignite Creation Date:
2024-05-06 @ 4:26 PM
Last Modification Date:
2024-10-26 @ 2:10 PM
Study NCT ID:
NCT04989322
Status:
RECRUITING
Last Update Posted:
2021-12-08
First Post:
2021-07-26
Brief Title:
Pembrolizumab Lenvatinib and Chemotherapy After TKIs in NSCLC
Sponsor:
Organization:
The University of Hong Kong